PCNA and cancer: In comparison to nonmalignant cells, accumulated evidence has shown that PCNA is overexpressed or posttranslationally modified in malignant cells [33,34,35,36,37], making it widely used as a biomarker in the diagnosis and prognosis of various cancers [38,39,40,41,42].